Blis Technologies has launched a new product UltraBLIS which is a unique combination of BLIS K12 with two gut probiotic strains. UltraBLIS is a next generation probiotic supplement targeted at those wanting to optimise their microbiome and strengthen overall immunity. BLIS K12 has strong evidence in the oral microbiome, and it has been combined in a lozenge format with Bifidobacterium lactis HN019 (HOWARU), and Lactobacillus acidophilus La14: 2 strains from Dupont that have strong evidence bases in immunity. The product will initially be available exclusively online from www.ultrablis.co.nz with planning for a NZ retail launch underway.